Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of preoperative (Pre-op), single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early-stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Comstock, C.; Maybody, M.; Sacchini, V.; Durack, J. C.; Blum, B.; Yuan, J. D.; Patil, S.; Neville, D. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS signaling
    Meeting Abstract

    Will, M.; Toy, W.; Yao, Z.; Poulikakos, P.; Rodrik-Outmezguine, V. ; Schneider, C.; Paul, J.; Baselga, J.; Liu, N.; Rosen, N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K- or NRAS-mutated melanoma
    Meeting Abstract

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Impact of trastuzumab-induced cardiotoxicity and cubsequent trastuzumab interruption on breast cancer outcome
    Meeting Abstract

    Yu, A. F.; Yadav, N. U.; Manrique, C. R.; Thaler, H. T.; Hudis, C. A.; Dang, C. T.; Steingart, R. M.
    Circulation (2013)

    Fulltext@MSK | Save
  • A comprehensive study to analyze tumor sensitivity to HSP90 inhibition therapy
    Meeting Abstract

    Riolo, M.; Modi, S.; Corben, A.; Hudis, C.; Alpaugh, M.; Chiosis, G.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas
    Meeting Abstract

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feedback dependent suppression of mitogenic signaling and its effect on RAF inhibition in BRAFV600E melanomas
    Meeting Abstract

    Lito, P.; Pratilas, C.; Joseph, E.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; de Stanchina, E.; Chandarlapaty, S.; Poulikakos, P.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Feasibility of long-term patient self-reporting of toxicities from home via the internet during routine chemotherapy
    Journal Article

    Judson, T. J.; Bennett, A. V.; Rogak, L. J.; Sit, L.; Barz, A.; Kris, M. G.; Hudis, C. A.; Scher, H. I.; Sabbatini, P.; Schrag, D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343
    Journal Article

    Hughes, K. S.; Schnaper, L. A.; Bellon, J. R.; Cirrincione, C. T.; Berry, D. A.; McCormick, B.; Muss, H. B.; Smith, B. L.; Hudis, C. A.; Winer, E. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
    Journal Article

    Hudis, C.; Swanton, C.; Janjigian, Y. Y.; Lee, R.; Sutherland, S.; Lehman, R.; Chandarlapaty, S.; Hamilton, N.; Gajria, D.; Knowles, J.; more...
    Breast Cancer Research (2013)

    Fulltext@MSK | Save